logo

For the Inventor, By the Inventor

Rueil Malmaison, France

Timur Gungor

USPTO Granted Patents = 9

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 137(Granted Patents)


Location History:

  • Rueil, FR (1993)
  • Rueil Malmatson, FR (1995)
  • Rueil Malmaison, FR (1993 - 1998)
  • Brandon Farms, NJ (US) (2000)

Company Filing History:

goldMedal6 out of 22 
 
Laboratoires Upsa
 patents
silverMedal2 out of 8 
 
Laboratories Upsa
 patents
bronzeMedal1 out of 1 
 
Societe Anonyme: Laboratoires Upsa
 patent

Years Active: 1993-2000

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6015797 - Adenosinergic agonist containing pharmaceutical composition with (2000-01-18),
2. 5723485 - 1,2-Diarylindole derivatives, processes for their preparation and their (1998-03-03),
3. 5480983 - Adenosine derivatives, preparation methods and pharmaceutical (1996-01-02),
4. 5459132 - N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide (1995-10-17),
5. 5389632 - Pyrazolopyrimidine derivatives which are angiotensin II receptor (1995-02-14),
6. 5387747 - Triazolopyrimidine derivatives which are angiotensin II receptor (1995-02-07),
7. 5231094 - Triazolopyrimidines which are angiotensin II receptor antagonists and (1993-07-27),
8. 5229505 - N.sup.6 -[3-(1-substituted)indolylethyl] adenosine 5'-carboxamides and (1993-07-20),
9. 5219839 - Adenosine derivatives, their methods of preparation and pharmaceutical (1993-06-15),

Title: The Innovative Mind of Timur Gungor

Introduction

Timur Gungor, an accomplished inventor based in Rueil Malmaison, France, has made significant contributions to the pharmaceutical field through his innovative work. Holding a total of 9 patents, Gungor's inventions reflect his dedication to advancing medical science and improving therapeutic options for various health conditions.

Latest Patents

Among his latest patents is a pharmaceutical composition that features an adenosinergic agonist combined with compounds selected from opiates, benzodiazepines, and NMDA antagonists. This innovative composition aims to enhance therapeutic efficacy in treating specific ailments. Furthermore, Gungor has developed 1,2-Diarylindole derivatives, which are detailed in his patent alongside processes for their preparation and therapeutic uses, particularly as drugs with anti-inflammatory and analgesic properties.

Career Highlights

Timur Gungor's career includes key roles at Laboratoires Upsa, where his research and development efforts spurred advancements in pharmaceutical formulations. His extensive knowledge and innovative approach have enabled him to contribute to numerous projects within the industry.

Collaborations

Throughout his career, Gungor has collaborated with esteemed professionals, including Jean-Marie C Teulon and Nicole Bru-Magniez. These collaborations have fostered a dynamic environment for sharing insights and enhancing the research and development process, ultimately benefiting their respective fields.

Conclusion

Timur Gungor stands out as a prominent inventor within the pharmaceutical industry, with a strong portfolio of patents that address critical health issues. His contributions not only demonstrate his expertise but also illustrate the impact of collaborative efforts in fostering innovation. With continued focus on research and development, Gungor's future work promises to bring forth even more groundbreaking inventions in the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…